Vaccinex up 26% on AACR presentations

|About: Vaccinex, Inc. (VCNX)|By:, SA News Editor

Ultra-thinly traded Vaccinex (VCNX +26%) is up on over 50% higher volume, albeit on turnover of only ~13K shares, on the heels of thee presentations at AACR related to its anti-SEMA4D technology.

The company states that the details of each of the three are on its website, but only the titles appear.

Subscribe for full text news in your inbox